NewCardio, Inc. (NWCI)

Market Cap	41.00
Revenue (ttm)	238.58K
Net Income (ttm)	-8.84M
Shares Out	40.81M
EPS (ttm)	-0.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	15,625
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0001
Beta	-123.18
RSI	46.30
Earnings Date	n/a

About Theseus Pharmaceuticals

NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company’s technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 10
• Stock Exchange: OTCMKTS
• Ticker Symbol: NWCI